scholarly article | Q13442814 |
P50 | author | Dani Bolognesi | Q109936341 |
Michael Skinner | Q38544315 | ||
Kent J. Weinhold | Q109935303 | ||
P2093 | author name string | M S Hershfield | |
T J Matthews | |||
J M Leeds | |||
S Chaffee | |||
P2860 | cites work | The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 |
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides | Q28360374 | ||
Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells | Q28622852 | ||
Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry | Q28646789 | ||
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule | Q28646808 | ||
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 | Q28646812 | ||
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV | Q28646817 | ||
An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion | Q34335264 | ||
Infection of monocyte/macrophages by human T lymphotropic virus type III. | Q34579117 | ||
Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus | Q34603040 | ||
Human immunodeficiency virus can productively infect cultured human glial cells | Q34625813 | ||
Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion | Q36353187 | ||
Infection of brain-derived cells with the human immunodeficiency virus | Q36886797 | ||
Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus | Q36887752 | ||
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody | Q37399845 | ||
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein | Q37412527 | ||
Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
Adenine and Adenosine Are Toxic to Human Lymphoblast Mutants Defective in Purine Salvage Enzymes | Q40094844 | ||
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. | Q40126058 | ||
The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain | Q41808623 | ||
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen | Q41830365 | ||
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity | Q43894349 | ||
HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens | Q44519991 | ||
Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay | Q44626333 | ||
Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines | Q45796470 | ||
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy | Q45836320 | ||
Human T lymphotropic virus type III infection of human alveolar macrophages. | Q45836633 | ||
In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). | Q45836762 | ||
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). | Q45838359 | ||
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope | Q45848174 | ||
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Q52828546 | ||
Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies | Q52833928 | ||
Human lymphoblastoid lines from lymph node and spleen | Q53438096 | ||
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. | Q53534022 | ||
Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia. | Q54452589 | ||
Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. | Q55244766 | ||
Productive HTLV-III infection of human B cell lines. | Q55245112 | ||
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point | Q68213583 | ||
AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells | Q68948945 | ||
Epitopes of the CD4 antigen and HIV infection | Q68977389 | ||
Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts | Q72848859 | ||
A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells | Q72876003 | ||
P4510 | describes a project that uses | AA-2 | Q54607564 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell line | Q21014462 |
P304 | page(s) | 605-621 | |
P577 | publication date | 1988-08-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines | |
P478 | volume | 168 |
Q73781366 | A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects |
Q34306804 | A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 |
Q44423892 | Adaptation of HIV-1 to pigtailed macaques |
Q39872431 | An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity |
Q28378612 | Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture |
Q36366846 | Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects |
Q40329035 | B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase |
Q33799700 | Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment |
Q33648180 | Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. |
Q36722526 | Design, Development, and Interpretation of HIV Neutralization Assays |
Q40043205 | Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: generation of revertant viruses to overcome defects in infectivity in specific cell types |
Q41165707 | Global analysis of lymphocyte gene expression: perturbation of H-9 cells by infection with distinct isolates of human immunodeficiency virus--an exposition by multivariate analysis of a host-parasite interface. |
Q36640831 | Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms |
Q29619512 | Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 |
Q33784777 | Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. |
Q28333970 | Inhibition of HIV-1 IIIb replication in AA-2 and MT-2 cells in culture by two ligands of poly (ADP-ribose) polymerase: 6-amino-1,2-benzopyrone and 5-iodo-6-amino-1,2-benzopyrone |
Q36699076 | Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1 |
Q35890968 | Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection |
Q33813173 | Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost |
Q36686530 | Quantitation of human immunodeficiency virus type 1 infection kinetics |
Q36365174 | Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 |
Q54607564 | AA-2 | described by source | P1343 |
Search more.